Keyphrases
Therapeutic Target
100%
Platelet-derived Growth factor-BB (PDGF-BB)
100%
Pathogenetic Significance
100%
Glial Cells
25%
Microenvironment
12%
Growth Factor Signaling
12%
Tumor Cells
12%
Mitogen
12%
Cancer Types
12%
Novel Therapeutics
12%
Tumor Microenvironment
12%
Parenchymal Cells
12%
Neurotransmission
12%
Tumorigenesis
12%
Neurovascular Unit
12%
Neuroprotective
12%
Neurological Diseases
12%
Mesenchymal Cells
12%
Neuron Cells
12%
Antiplatelet
12%
Homeostatic Control
12%
Chemoattractant
12%
Connective Tissue Disease
12%
Vascular Abnormalities
12%
Connective Tissue Cells
12%
Growth Factor Therapy
12%
Medicine and Dentistry
Platelet Derived Growth Factor
100%
Microglia
18%
Disease
9%
Receptor
9%
Connective Tissue
9%
Tumor Cell
9%
Carcinogenesis
9%
Malignant Neoplasm
9%
Tumor Microenvironment
9%
Neuroprotective Agent
9%
Neurologic Disease
9%
Mitogenic Agent
9%
Antiplatelet
9%
Chemoattractant
9%
Synaptic Transmission
9%
Connective Tissue Disease
9%
Neuroscience
Platelet-Derived Growth Factor
100%
Microglia
18%
Connective Tissue
18%
Carcinogenesis
9%
Synaptic Transmission
9%
Neuroprotective Agent
9%
Nervous System Disorder
9%
Receptor
9%
Immunology and Microbiology
Platelet Derived Growth Factor
100%
Microglia
18%
Connective Tissue
18%
Mitogen
9%
Tumor Cell
9%
Chemoattractant
9%
Synaptic Transmission
9%
Biochemistry, Genetics and Molecular Biology
Platelet-Derived Growth Factor
100%
Microglia
18%
Glial Cells
18%
Genetics
9%
Carcinogenesis
9%
Synaptic Transmission
9%